Prasol Chemicals IPO Logo

Prasol Chemicals IPO

Live Updates, GMP, Subscription Data, and Financial Details

IPO Overview

Live
Dates Sep 08 to Sep 10 2026
Price Band ₹643 - 676
Current GMP ₹0 (0%)
Subscription 0.76 times

IPO Details

IPO Date
8 to 10 Sep, 2026
Listing Date
Wed, Sep 16, 2026
Face Value
₹ 2 per share
Price Band
₹643 to ₹676
Lot Size
22 Shares
Sale Type
Fresh capital cum OFS
Issue Type
Bookbuilding IPO
Listing At
BSE, NSE
Total Issue Size
73,96,437 shares (agg. up to ₹ 500 Cr)
Fresh Issue
11,83,431 shares (agg. up to ₹ 80 Cr)
Offer for Sale
62,13,006 shares of ₹ 2 (agg. up to ₹ 420 Cr)
Share Holding Pre Issue
5,80,00,000 shares
Share Holding Post Issue
5,91,83,431 shares

IPO Subscription Details

Anchor
1
QIB (Ex Anchor)
0.06
NII
0.69
bNII (> ₹10L)
0.39
sNII (< ₹10L)
1.31
Retail
1.19
Total **
0.76

Day Wise Sub

DaySep 8 (Day 1)
QIB (Ex Anchor)0.00
NII0.33
NII (> ₹10L)0.17
NII (< ₹10L)0.64
Retail0.74
Total0.44
DaySep 9 (Day 2)
QIB (Ex Anchor)0.06
NII0.69
NII (> ₹10L)0.39
NII (< ₹10L)1.31
Retail1.19
Total0.76

Day Wise GMP

GMP Date09-09-2026
IPO Price676
GMP0 (0%)
Est. Listing Price676
GMP Date08-09-2026
IPO Price676
GMP30 (4.44%)
Est. Listing Price706
GMP Date07-09-2026
IPO Price676
GMP55 (8.14%)
Est. Listing Price731
GMP Date06-09-2026
IPO Price676
GMP115 (17.01%)
Est. Listing Price791
GMP Date05-09-2026
IPO Price676
GMP125 (18.49%)
Est. Listing Price801
GMP Date04-09-2026
IPO Price676
GMP165 (24.41%)
Est. Listing Price841
GMP Date03-09-2026
IPO Price676
GMP14 (2.07%)
Est. Listing Price690

IPO Important Dates

IPO Open
Tue, Sep 8, 2026
IPO Close
Thu, Sep 10, 2026
Allotment
Fri, Sep 11, 2026
Refund
Tue, Sep 15, 2026
Credit of Shares
Tue, Sep 15, 2026
Listing
Wed, Sep 16, 2026

IPO Lot Size

ApplicationRetail (Min)
Lots1
Shares22
Amount₹14,872
ApplicationRetail (Max)
Lots13
Shares286
Amount₹1,93,336
ApplicationS-HNI (Min)
Lots14
Shares308
Amount₹2,08,208
ApplicationS-HNI (Max)
Lots67
Shares1474
Amount₹9,96,424
ApplicationB-HNI (Min)
Lots68
Shares1496
Amount₹10,11,296

Financial Information

Period EndedAssets
31 Mar 2026839.28
31 Mar 2025723.09
31 Mar 2024626.36
Period EndedTotal Income
31 Mar 20261,237.85
31 Mar 20251,015.54
31 Mar 2024887.56
Period EndedProfit After Tax
31 Mar 202683.12
31 Mar 202543.57
31 Mar 202418.13
Period EndedEBITDA
31 Mar 2026139.32
31 Mar 202587.77
31 Mar 202460.53
Period EndedNET Worth
31 Mar 2026448.51
31 Mar 2025367.46
31 Mar 2024325.84
Period EndedReserves and Surplus
31 Mar 2026436.91
31 Mar 2025355.87
31 Mar 2024314.24
Period EndedTotal Borrowing
31 Mar 2026110.06
31 Mar 2025101.05
31 Mar 202482.07

Key Performance Indicator

ROE
20.37%
ROCE
22.43%
Debt/Equity
0.19
RoNW
18.53%
PAT Margin
6.74%
EBITDA Margin
11.30%
NAV
77.33

IPO Reservation

QIB
36,98,219
− Anchor Investor
22,18,930
− QIB (Ex. Anchor)
14,79,289
NII (HNI)
11,09,466
− bNII > ₹10L
7,39,644
− sNII < ₹10L
3,69,822
Retail
25,88,753
Total
73,96,438

Information about company

Incorporated in 1992, Prasol Chemicals operates in the specialty chemicals industry. The company manufactures over 150 specialty chemicals, including acetone-based, phosphorous-based, and other complex chemicals. Its product portfolio includes 21 acetone-based chemicals, 53 phosphorous-based chemicals, and 76 other specialty chemicals (e.g. surfactants, esters, acids). The products serve 5 major industries, including Performance chemicals (like lubricant and mining additives), paint, inks, construction, and adhesives (PICA), pharmaceuticals, agrochemicals, and home and personal care. Manufacturing Facility: The company operates two manufacturing facility in Khopoli across 1,20,604 sq. m., Mahad across 1,19,423 sq. mt with an aggregate capacity of 98,644 MT per year. Key customers: Alembic Pharmaceuticals, Lubrizol India, Rossari Biotech, Clean Science, Gharda Chemicals, Croda India, Supriya Lifescience, Yasho Industries, etc. As of July 31, 2026, the company served 1600 customers and exports to 69 countries. It is certified as a 3 Star Export House by the Indian government and have a strong global distribution network across APAC, North and South America, and Europe. Competitive Strengths:

Objectives of IPO

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: #: Issue Objects 1: Repayment and/ or pre-payment, in full or part, of certain borrowings availed by the company 2: General Corporate Purposes : Total

Disclaimer

All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application. No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever Please read all Tearms and conditions , and agree to use the App